Infinium Pharmachem Ltd. IPO
IPO Timeline
Category-wise Subscription
| Category | Sub (x) | Offered | Bid For | Amt (Cr)* |
|---|---|---|---|---|
| NII (HNI) | — | 870,000 (46%) | — | ₹1,175 Cr |
| Retail | — | 870,000 (46%) | — | ₹1,175 Cr |
| Market Maker | — | 94,000 (5%) | — | ₹13 Cr |
| Σ Total | — | 1,875,000 (100%) | — | ₹25,313 Cr |
Only available investor categories are shown. Amount is auto-calculated when shares offered and issue price are available.
Issue Details
Minimum Investment (Lot-wise)
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 1,000 | ₹135,000 |
| Retail (Max) | 13 | 13,000 | ₹1,755,000 |
| S-HNI (Min) | 14 | 14,000 | ₹1,890,000 |
| B-HNI (Min) | 67 | 67,000 | ₹9,045,000 |
Financial Statements Amount in ₹ Lakhs
| Metric | 30-Sep-22 | 31-Mar-22 | 31-Mar-21 |
|---|---|---|---|
| Revenue | 7,985 | 10,005 | 7,115 |
| Profit After Tax | 551 | 611 | 272 |
| Net Worth | 1,856 | 1,310 | 702 |
| Total Assets | 7,076 | 5,900 | 3,418 |
| Total Borrowing | 1,615 | 1,385 | 579 |
Valuation & Key Ratios
Grey Market Premium (GMP)
GMP is an unofficial grey market indicator and does not guarantee actual listing price. Invest at your own risk.
Objects of the Issue
- Marketing and Branding Expenses (including Registration in Reach - Europe, other marketing expenses) – 1.13
- Repayment of some of Existing Loans; – 3.92
- Expansion of Existing Unit – 5.05
- To Meet Incremental Working Capital Requirements; – 10.10
- General Corporate Purpose – 4.43
Company Overview
Incorporated in 2003, Infinium Pharmachem Limited manufactures & supplies Iodine Derivatives, APIs, and Iodination reaction-based bulk drugs.
The company offers R & D services and commercial scale manufacturing and packaging for Pharmaceutical, Agrochemical, Nutraceutical, Speciality Chemicals & other chemical industries.
Infinium Pharmachem's manufacturing plant is located in Gujarat - INDIA, which spans across 4100 Sq. Mtr. Plot area. The facility is FDA certified & GMP compliant with capabilities of producing complex Iodine Derivatives.
The company serves to over 15+ countries across the globe and has over 200+ Iodine Derivatives and 7+ APIs.